Providing crucial early-stage financing, e2 supports technology-centric startups aiming to disrupt traditional industries within the Turkish market.
About e2 Ventures
e2 Ventures is an Istanbul-based pre-seed and seed fund providing early-stage financing to Turkish technology startups disrupting traditional industries, with healthcare appearing as one application sector. Checks are below $250k and AI is not flagged as a primary focus. The fund occupies the very early end of the Turkish venture stack, where institutional capital is genuinely scarce and a small early check from a credible local fund can be the difference between a company existing and not. The right founder for e2 is a Turkish operator with strong technical or commercial credentials, often first-time founders, building a digital health, telehealth, healthcare software, or tech-enabled care business with a credible Turkish-market wedge and either CEE or MENA regional expansion logic. The wrong founder is a Series A-ready company, a deep medtech or therapeutics team, or a non-Turkish founder using Istanbul as a satellite. Intro paths run through Istanbul’s increasingly networked startup community, including the StartersHub, Workup, and TechStars Istanbul ecosystems, through frequent co-investors such as 212, Earlybird Digital East, and Maxis VC, and through angels in the Turkish operator network including senior figures from Trendyol, Hepsiburada, and Peak Games. Direct outreach is read but warm intros help materially. In the pitch, lead with the founding team’s depth, the unit economics in Turkish Lira with realistic FX assumptions, and a clear-eyed view of how the Turkish lira’s volatility shapes pricing, hiring, and runway planning. Be specific about Ministry of Health Turkey regulatory posture, KVKK data protection compliance, and the public-private payer dynamic where SGK is the dominant payer for most healthcare and private supplemental insurance is growing but limited. Show a credible plan to expand into either CEE or MENA, since Turkey alone is a meaningful but not unlimited healthcare market. Caveats are real. Turkish venture has been buffeted by macro and currency volatility, follow-on syndicate construction is harder than in comparable markets, and many Turkish founders eventually choose to redomicile their holding company in Delaware, the UK, or the Netherlands to ease global capital raising; founders should think about this structure early. For early-stage Turkish healthcare operators, e2 is a credible first-check partner; the heavy lifting of building the rest of the round is the founder’s job.
Founder reviews
Healthcare AI tools backed by e2 Ventures
Tools made by companies in e2 Ventures's portfolio that we cover in the directory.
Portfolio companies in our directory
Other portfolio companies
Companies in e2 Ventures's portfolio not currently in our directory.
- Altera Biosciences · 2025
Team
Pitch / review this investor
Have you raised from e2 Ventures? Founders only — share your honest experience (anonymous OK, moderated before publishing).


